Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT06489990

Implementation Research on the Intervention Mode of " Comorbidity-Co-causes-Joint-prevention" Comprehensive Demonstration District of Depression and Obesity Among Children and Adolescents in Beijing

Depression and obesity have become the most prominent health problems among adolescents and have caused a heavy burden on the health and social economy of the whole population. There are high incidence, comorbidity and co-pathogenic factors of depression and obesity in adolescents, but there is still a lack of research on joint prevention strategies and multi-sectoral collaborative prevention and control network. This project plans to screen and integrate effective intervention measures based on multi-stage optimization strategy, developing an intervention mode of [Comorbidity-Co-causes-Joint-prevention] for adolescents with depression or/and obesity, and then carry out with children or adolescents in Beijing based on digital platform. The investigators will be considering the accessibility, sustainability and replicability of the implement based on the RE-AIM framework including the coverage of population and organizations as well as the effect, implement and sustainability of the interventions. The research will be promoted with the help of the National Clinical Research Center for Mental Disorders and Monitoring of Student Common Diseases and Health Influencing Factors. The results of the research will establish an intervention mode of [Comorbidity-Co-causes-Joint-prevention] and a promotion model for adolescents' depression and obesity in Beijing, providing support for the realization of Healthy China 2030 and Healthy Beijing 2030 Plans.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Depression Behavior Behavioral Symptoms Body Weight High Risk of Depression Nutrition Disorders Nutritional and Metabolic Diseases Obesity Overnutrition Overweight Pathological Conditions, Signs and Symptoms Signs and Symptoms

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Beijing Anding Hospital, Capital Medical University

Beijing, Beijing Municipality, 100088, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Stage I (screening stage):
  • Middle school students in Beijing Economic-Technological Development Area and other districts of Beijing, both male and female;
  • Students themselves and their guardians are willing to participate in this study and sign written informed consent file.

Stage Ⅱ:

Middle school students who were identified as high risk of depression and/or obesity in Stage I in Beijing Economic-Technological Development Area and other districts of Beijing, the screening criteria are as follows:

① CES-DC score ≥16 points;

② BMI ≥WS/T586-2018: Screened as overweight and obesity among school-age children and adolescents, according to the recommendation by the National Health Commission;

③ Students themselves and their guardians are willing to participate in this study and provide written informed consent.

Exclusion criteria

  • Stage I:
  • Having serious physical or genetic disease that is not suitable for participation in the study;
  • Have been evaluated that not suitable for this study by investigators.

Stage Ⅱ:

  • Having serious physical or genetic disease that is not suitable for participation in the study;
  • Have been evaluated that not suitable for this study by investigators.

Treatment and study plan

combination intervention strategy of [Comorbidity-Co-causes-Joint-prevention]

Combination Product

combination intervention strategy of [Comorbidity-Co-causes-Joint-prevention]

routine health education and mental health knowledge

Combination Product

routine health education and mental health knowledge

Primary outcomes

  1. Patient Health Questionnaire-9(PHQ-9)

    Time frame: From enrollment to the end of treatment at baseline、12weeks、6months

    The score ranges from 0 to 27, the higher scores mean more serious depression

Secondary outcomes

  1. BMI

    Time frame: From enrollment to the end of treatment at baseline、12 weeks、6months

Study contacts

Contact information is provided by the study sponsor or research team.

Linghui Meng, PHD

CONTACT

[email protected]

86 18210344972

Pingping Gui

CONTACT

[email protected]

86 13253610521

Sponsors and collaborators

Lead sponsor

Capital Medical University

Other

Collaborators

  • Center for Disease Control and Prevention of Bejing Economic-Technoloogical Develeopment Area
  • Peking University

Registry information

Important dates

Study start
2024
Primary completion
2026
Study completion
2026
First posted
Jul 8, 2024
Registry last updated
Jul 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.